Gastrointestinal Intervention, 2018 Background: To evaluate the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) creation for the management of portal hypertension in patients with hepatocellular carcinoma (HCC). Methods: A literature search of the MEDLINE/PubMed
He Zhao +5 more
doaj +1 more source
Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt. [PDF]
, 2016 Cirrhotic patients with recurrent variceal bleeds who have failed prior medical and endoscopic therapies and are not transjugular intrahepatic portosystemic shunt candidates face a grim prognosis with limited options.
Borum, Marie L +2 more
core +2 more sources
Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: Characterization of cell phenotype and function [PDF]
Hepatology, 1998 The clinical utility of transjugular intrahepatic portasystemic shunts (TIPS) is frequently complicated by the ingrowth of tissue into the stent lumen, causing stent stenosis. These studies were undertaken to define the cellular and matrix components of the pseudointima, define the phenotype and function of the mesenchymal ...
A J, Sanyal +5 more
openaire +2 more sources
The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status [PDF]
, 2012 The transjugular intrahepatic portosystemic shunt (TIPS) represents a major advance in the treatment of complications of portal hypertension. Technical improvements and increased experience over the past 24 years led to improved clinical results and a ...
Dave Guérette +5 more
core +2 more sources
Portosystemic shunt without surgery [PDF]
, 1992 Objective. – To determine the effectiveness of the Palmaz balloon expandable stent for the creation of a transjugular intrahepatic portosystemic shunt. The device is designed to achieve portal decompression in patients with variceal hemorrhage secondary
Brems +7 more
core +1 more source
Percutaneous transjugular portosystemic shunt: Commentary on the technical aspects of this new procedure [PDF]
, 1992 No Abstract.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/38374/1/1840150334_ftp ...
Marx, M. Victoria, Williams, David M.
core +1 more source
International Journal of Gastrointestinal InterventionPortal hypertension, a known complication of liver cirrhosis, typically leads to variceal bleeding in the esophagus and stomach. However, ectopic varices can also occur outside the gastroesophageal region and may present with life-threatening massive ...
Saurabh Kumar +3 more
doaj +1 more source
Easy to say, hard to do. To the anniversary of two fundamental discoveries. Part 2 [PDF]
, 2022 On the eve of the anniversaries of two historical events: the 145th anniversary of the experiments in which Eck's fistula was performed and the 55th anniversary of the successful clinical approbation of the selective distal splenorenal anastomosis, a ...
A. Yu. Anisimov
core +2 more sources
Особенности развития и течения осложнений цирроза печени в зависимости от этиологического фактора [PDF]
, 2013 ВАРИКОЗНОЕ РАСШИРЕНИЕ ВЕНГЕПАТИТ ВИРУСНЫЙ ЧЕЛОВЕКАЖЕЛУДОКПИЩЕВОДПОРТОСИСТЕМНЫЙ ШУНТ ХИРУРГИЧЕСКИЙЦИРРОЗ ...
Бабаджанов, А. Ф. +3 more
core
Journal of Digestive Diseases, Volume 25, Issue 3, Page 200-208, March 2024.The gut–liver axis is discussed to play an important role in hepatic cirrhosis. Decompensated liver cirrhosis is often associated with portal hypertension, which can lead to a variety of complications. The application of transjugular intrahepatic portosystemic shunt (TIPS) is an established treatment option for the complications of portal hypertension.
Thomas Heller +9 more
wiley +1 more source